The Eli Lilly CEO is placing his bets on tailored AI models to seal the deal on scientific advancements. During the interview, he noted that most LLMs fail to master the nuance required to deal with biology, something he thinks models trained on advanced and specific data could one day achieve.
Последние новости。体育直播对此有专业解读
——阿里巴巴原首席执行官 马云，更多细节参见体育直播
В МОК высказались об отстранении израильских и американских спортсменов20:59